Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease
about
Antithyroid drug regimen for treating Graves' hyperthyroidismThe treatment of Graves' disease in children and adolescentsPediatric Graves' disease: management in the post-propylthiouracil EraHypothyroidism and its rapid correction alter cardiac remodelingHyperthyroidismThe thioamides methimazole and thiourea inhibit growth of M. avium Subspecies paratuberculosis in cultureGuidelines for the treatment of childhood-onset Graves' disease in Japan, 2016Antithyroid Drug Therapy for Graves' Disease and Implications for Recurrence.Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyroidism and trilogy of Fallot: case report.Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008.Factors affecting drug-induced liver injury: antithyroid drugs as instances.Antithyroid drug-related hepatotoxicity in hyperthyroidism patients: a population-based cohort study.Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancyLesion of the olfactory epithelium accelerates prion neuroinvasion and disease onset when prion replication is restricted to neurons.Pediatric pulmonary arterial hypertension and hyperthyroidism: a potentially fatal combination.Propylthiouracil increases sodium/iodide symporter gene expression and iodide uptake in rat thyroid cells in the absence of TSH.Antioxidant and Protective Effects of Bupleurum falcatum on the L-Thyroxine-Induced Hyperthyroidism in Rats.Current concepts in graves' disease.Thyroid storm masked by hemodialysis and glucocorticoid therapy in a patient with rheumatoid arthritisHyperthyroidism in childhood: causes, when and how to treat.Clinical experience with radioactive iodine in the treatment of childhood and adolescent Graves' disease.Initial Treatment of Pediatric Graves' Disease with Methimazole: A Retrospective Follow-up Study.Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).Frequency of Adverse Events of Antithyroid Drugs Administered during Pregnancy.Antithyroid Arthritis Syndrome: A Case Report and Review of the Literature.Relationship between dose of antithyroid drugs and adverse events in pediatric patients with Graves' diseaseToxicological considerations for antithyroid drugs in children.Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.Evaluation of drug-induced injury and human response in precision-cut tissue slices.Propylthiouracil, and methimazole, and carbimazole-related hepatotoxicity.An update on the medical treatment of Graves' hyperthyroidism.Zwitterionic structures: from physicochemical properties toward computer-aided drug designs.Current trends in antithyroid drug treatment of Graves' disease.Controversies in the management of Graves' disease in children.Incidence of abnormal liver biochemical tests in hyperthyroidism.Recovery following Thyroxine Treatment Withdrawal, but Not Propylthiouracil, Averts In Vivo and Ex Vivo Thyroxine-Provoked Cardiac Complications in Adult FVB/N Mice.Treatment and management of thyroid storm: analysis of the nationwide surveys: The taskforce committee of the Japan Thyroid Association and Japan Endocrine Society for the establishment of diagnostic criteria and nationwide surveys for thyroid stormLiver Effects of Clinical Drugs Differentiated in Human Liver Slices.Fast Electrocatalytic Determination of Methimazole at an Activated Glassy Carbon ElectrodeThyroid Storm: A Japanese Perspective.
P2860
Q24240873-FDE3D412-555A-4913-9ABF-E145A9DDEDECQ26829000-99F945C2-D872-4A23-97B3-B7B3DF5F40E0Q26864019-98DF27C6-47AB-42E1-B091-FBC186711394Q27339180-EC279A09-3D2C-4AC3-8439-1C468052AD64Q27690661-CCC67028-378A-4EB9-87AD-D7E205EB1F17Q28751585-D084DF1A-C1F3-499F-9824-881CCE47F64CQ33594405-A1949581-F481-4455-98D8-37B059C40630Q33655557-3ADF25C3-D80E-46D5-A0BE-99D8551EE47CQ33657513-2C296AB3-2643-4F63-B903-3426725F31A9Q33849471-0098D468-56D6-406B-A9D1-3FD69CF178F6Q34339590-C6CE24B0-94CA-4E40-9F67-AAD77A02D331Q34571094-4E613F1C-C63E-40AC-8B23-93918B62ED72Q35160028-BF205F0F-D4B5-4F31-9441-53A90751B6EFQ35231240-EE194F62-179D-4FF6-971F-CEE9A824909DQ36069803-86C0ADDE-FCA0-4287-8C6A-0DD36F979147Q36124300-F0465FDE-1802-450C-BB29-59A468ED6820Q36135055-7E40735C-6E3A-4103-BC43-7E69656D0FCBQ36328020-3A064E9E-B468-4085-A0C2-FD483A13BFA4Q36350093-BC21CDDB-19DA-427A-BAAA-08604515DF33Q36715841-2EA18978-0655-4168-97C5-E654AFF23D00Q36924568-A7B65846-39C8-470E-970A-8DEAE6088A79Q36943160-736A8EED-FBC1-4421-80C7-BBC206871AC8Q37521098-6ACDE67F-BCC2-4582-9C03-9AC27218E13CQ37552542-6451487F-1747-4778-9B6B-B9E8EAB60ADFQ37616836-513AD5AF-268C-4136-BADA-0609FEB49254Q37628656-E534A2C6-7895-4463-A18E-F27226CFE759Q37842518-53E27881-92EA-4BBC-A711-36471580D89DQ38016064-FEDAF596-354F-467B-AEC5-B20023BBA015Q38055199-5712B0A2-516A-481C-8DA4-A247ECA641B6Q38243292-DB3BE4E1-0B9F-4EBF-A5C1-9C4F630CC2E6Q38245840-10C5941A-E379-4EFE-B36B-A63256B49220Q38792090-74762970-EEBA-4DC2-970E-8305F78D098BQ38822451-409356A9-DEA2-43D7-96EA-B279DFECB628Q38827752-0DCD09D6-58C2-4E0C-BD1F-BA746AD9FA66Q40443981-0E915ECD-496C-48FE-8F65-B469886CF342Q41169082-FD4F2D5B-C5C4-4C5B-B1BE-0BED23B5A69AQ41342196-F3969E13-4469-4A50-8D40-255568AFEFAFQ41951728-BDA1BEBE-D1D1-464E-8FFC-4F99D2B8F61DQ42182712-AA85138B-87F9-4E8E-BE47-B66642549F3BQ47689965-3D94B9E8-E567-45B8-9701-8354E20C7228
P2860
Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Comparison of methimazole and ...... dism caused by Graves' disease
@ast
Comparison of methimazole and ...... dism caused by Graves' disease
@en
Comparison of methimazole and ...... dism caused by Graves' disease
@nl
type
label
Comparison of methimazole and ...... dism caused by Graves' disease
@ast
Comparison of methimazole and ...... dism caused by Graves' disease
@en
Comparison of methimazole and ...... dism caused by Graves' disease
@nl
prefLabel
Comparison of methimazole and ...... dism caused by Graves' disease
@ast
Comparison of methimazole and ...... dism caused by Graves' disease
@en
Comparison of methimazole and ...... dism caused by Graves' disease
@nl
P2093
P356
P1476
Comparison of methimazole and ...... dism caused by Graves' disease
@en
P2093
Hirotoshi Nakamura
Jaeduk Yoshimura Noh
Koichi Itoh
Noboru Hamada
Shuji Fukata
P304
P356
10.1210/JC.2006-2135
P407
P577
2007-06-01T00:00:00Z